1.        Introduction

1.1      The Insight Partners Research Report Guidance

1.2      Market Segmentation

2.        Executive Summary

2.1      Key Insights

3.        Research Methodology

3.1      Secondary Research

3.2      Primary Research

3.2.1       Hypothesis formulation:

3.2.2       Macro-economic factor analysis:

3.2.3       Developing base number:

3.2.4       Data Triangulation:

3.2.5       Country level data:

4.        North America Gastrointestinal Drugs Market Landscape

4.1      Overview

4.2      PEST Analysis

5.        North America Gastrointestinal Drugs Market – Key Market Dynamics

5.1      Market Drivers

5.1.1       Rising Cases of Gastrointestinal Diseases

5.1.2       Increasing Development of Biologics

5.2      Market Restraints

5.2.1       High Cost of Biologics

5.2.2       Average Cost of Biologic Drugs for Severe Ulcerative Colitis or Crohn's Disease

5.3      Market Opportunities

5.3.1       Strategic Initiatives by Companies

5.4      Future Trends

5.4.1       Increasing Research Investment for Novel Drug Development and Artificial Intelligence-Based Techniques

5.5      Impact of Drivers and Restraints:

6.        Gastrointestinal Drugs Market – North America Analysis

6.1      North America Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031

7.        North America Gastrointestinal Drugs Market Analysis – by Drug Class

7.1      Biologics

7.1.1       Overview

7.1.2       Biologics: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.2      Antidiarrheal and Laxatives

7.2.1       Overview

7.2.2       Antidiarrheal and Laxatives: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

7.3      Acid Neutralizers

7.3.1       Overview

7.3.2       Acid Neutralizers: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.4      Anti-inflammatory Drugs

7.4.1       Overview

7.4.2       Anti-inflammatory Drugs: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

7.5      Antiemetic and Antinauseants

7.5.1       Overview

7.5.2       Antiemetic and Antinauseants: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

7.6      Others

7.6.1       Overview

7.6.2       Others: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.        North America Gastrointestinal Drugs Market Analysis – by Application

8.1      Irritable Bowel Syndrome

8.1.1       Overview

8.1.2       Irritable Bowel Syndrome: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.2      Inflammatory Ulcerative Colitis

8.2.1       Overview

8.2.2       Inflammatory Ulcerative Colitis: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031  (US$ Million)

8.3      Crohns Disease

8.3.1       Overview

8.3.2       Crohns Disease: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.4      Gastroenteritis

8.4.1       Overview

8.4.2       Gastroenteritis: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.5      Celiac Disease

8.5.1       Overview

8.5.2       Celiac Disease: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

8.6      Others

8.6.1       Overview

8.6.2       Others: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.        North America Gastrointestinal Drugs Market Analysis – by Route of Administration

9.1      Oral

9.1.1       Overview

9.1.2       Oral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

9.2      Parenteral

9.2.1       Overview

9.2.2       Parenteral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.      North America Gastrointestinal Drugs Market Analysis – by Distribution Channel

10.1    Hospital Pharmacies

10.1.1     Overview

10.1.2     Hospital Pharmacies: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.2    Retail Pharmacies

10.2.1     Overview

10.2.2     Retail Pharmacies: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

10.3    Online Pharmacies

10.3.1     Overview

10.3.2     Online Pharmacies: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.      North America Gastrointestinal Drugs Market – Country Analysis

11.1    North America

11.1.1     North America Gastrointestinal Drugs Market Overview

11.1.2     North America Gastrointestinal Drugs Market – Breakdown, by Key Countries, 2023 and 2031 (%)

11.1.2.1       United States: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.1.2.1.1      United States: North America Gastrointestinal Drugs Market Breakdown, by Drug Class

11.1.2.1.2      United States: North America Gastrointestinal Drugs Market Breakdown, by Application

11.1.2.1.3      United States: North America Gastrointestinal Drugs Market Breakdown, by Route Of Administration

11.1.2.1.4      United States: North America Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.1.2.2       Canada: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.1.2.2.1      Canada: North America Gastrointestinal Drugs Market Breakdown, by Drug Class

11.1.2.2.2      Canada: North America Gastrointestinal Drugs Market Breakdown, by Application

11.1.2.2.3      Canada: North America Gastrointestinal Drugs Market Breakdown, by Route Of Administration

11.1.2.2.4      Canada: North America Gastrointestinal Drugs Market Breakdown, by Distribution Channel

11.1.2.3       Mexico: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

11.1.2.3.1      Mexico: North America Gastrointestinal Drugs Market Breakdown, by Drug Class

11.1.2.3.2      Mexico: North America Gastrointestinal Drugs Market Breakdown, by Application

11.1.2.3.3      Mexico: North America Gastrointestinal Drugs Market Breakdown, by Route Of Administration

11.1.2.3.4      Mexico: North America Gastrointestinal Drugs Market Breakdown, by Distribution Channel

12.      Industry Landscape

12.1    Overview

12.2    Growth Strategies in North America Gastrointestinal Drugs Market

12.3    Organic Growth Strategies

12.3.1     Overview

12.4    Inorganic Growth Strategies

12.4.1     Overview

13.      Company Profiles

13.1    Sanofi SA

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2    GSK Plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3    Johnson & Johnson

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4    Bausch Health Companies Inc

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5    AstraZeneca Plc

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6    Takeda Pharmaceutical Co Ltd

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7    AbbVie Inc

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8    Bayer AG

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9    Celltrion Inc

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

13.10  Pfizer Inc

13.10.1   Key Facts

13.10.2   Business Description

13.10.3   Products and Services

13.10.4   Financial Overview

13.10.5   SWOT Analysis

13.10.6   Key Developments

14.      Appendix

14.1    About The Insight Partners

14.2    Glossary of Terms

List of Tables

Table 1.          North America Gastrointestinal Drugs Market Segmentation

Table 2.          United States: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 3.          United States: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 4.          United States: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 5.          United States: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 6.          Canada: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 7.          Canada: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 8.          Canada: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 9.          Canada: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 10.        Mexico: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Drug Class

Table 11.        Mexico: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Application

Table 12.        Mexico: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Route Of Administration

Table 13.        Mexico: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million) – by Distribution Channel

Table 14.        Recent Organic Growth Strategies in North America Gastrointestinal Drugs Market

Table 15.        Recent Inorganic Growth Strategies in the North America Gastrointestinal Drugs Market

Table 16.        Glossary of Terms, North America Gastrointestinal Drugs Market

List of Figures

Figure 1.         North America Gastrointestinal Drugs Market Segmentation, by Country

Figure 2.         PEST Analysis

Figure 3.         North America Gastrointestinal Drugs Market – Key Market Dynamics

Figure 4.         Impact Analysis of Drivers and Restraints

Figure 5.         North America Gastrointestinal Drugs Market Revenue (US$ Million), 2021–2031

Figure 6.         North America Gastrointestinal Drugs Market Share (%) – by Drug Class (2023 and 2031)

Figure 7.         Biologics: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 8.         Antidiarrheal and Laxatives: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 9.         Acid Neutralizers: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 10.      Anti-inflammatory Drugs: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 11.      Antiemetic and Antinauseants: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 12.      Others: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 13.      North America Gastrointestinal Drugs Market Share (%) – by Application (2023 and 2031)

Figure 14.      Irritable Bowel Syndrome: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 15.      Inflammatory Ulcerative Colitis: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 16.      Crohns Disease: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 17.      Gastroenteritis: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 18.      Celiac Disease: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 19.      Others: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 20.      North America Gastrointestinal Drugs Market Share (%) – by Route Of Administration (2023 and 2031)

Figure 21.      Oral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 22.      Parenteral: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 23.      North America Gastrointestinal Drugs Market Share (%) – by Distribution Channel (2023 and 2031)

Figure 24.      Hospital Pharmacies: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 25.      Retail Pharmacies: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 26.      Online Pharmacies: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031 (US$ Million)

Figure 27.      North America Gastrointestinal Drugs Market Breakdown, by Key Countries – Revenue (2023) (US$ Million)

Figure 28.      North America Gastrointestinal Drugs Market Breakdown, by Key Countries, 2023 and 2031 (%)

Figure 29.      United States: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 30.      Canada: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 31.      Mexico: North America Gastrointestinal Drugs Market – Revenue and Forecast to 2031(US$ Million)

Figure 32.      Growth Strategies in North America Gastrointestinal Drugs Market